Pro PG receives S19A for AMOXICILLIN/CLAVULANATE POTASSIUM for Oral Suspension, USP, 400mg/57mg

Dear Healthcare Professional, Shortage of CURAM DUO 400/57 amoxicillin/clavulanic acid powder for suspension bottle (AUST R 147109). Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you of the change in supply status of CURAM DUO 400/57 amoxicillin/clavulanic acid powder for suspension bottle (AUST R 147109) in Australia. The Australian registered medicine, CURAM DUO 400/57 amoxicillin/clavulanic acid powder for suspension bottle (AUST R 147109) Sponsor: Sandoz Pty Ltd is currently in shortage due to manufacturing issues. Pro Pharmaceuticals Group has arranged for the supply of an alternative product, Amoxicillin and clavulanate potassium for oral suspension, USP 400mg/57mg per 5mL (Aurobindo). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 30th June 2023

Pre-Orders only at this stage and domestic delivery rates may apply

Registered Pro Pharm Member Pharmacies can Log into our website www.propg.com.au and visit Pharmacy Online Ordering to see Product Details including Pricing, Availability and also do any Pre-Orders.

Not a Registered Pro Pharm Member? Then Register Today by visiting our website and going to Pharmacy Online Ordering.

Please note Pro Pharmaceuticals Group is a Wholesaler and not a Pharmacy and can not supply to members of the Public, if you are a member of the Public please visit your Pharmacy to discuss.